As Covid-19 escalated, investors doubled down on alternative proteins, gaming, and fitness.
After delaying a CAR-T test and with time on its hands, Anixa Biosciences is working with Germany-based computational company OntoChem to find new antiviral meds for COVID-19.
Having two copies of e4 variant of ApoE gene linked to double risk of severe Covid-19, study suggests
An expert said the study can't draw this conclusion.
Advances in gene sequencing have allowed scientists to trace and monitor the COVID-19 pandemic faster than any previous outbreak. However, gaps in our knowledge of how coronaviruses work ...
Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.
Consumer products like at-home fitness, gaming, and food & beverage garnered investor attention in Q1'20.
Government officials are weighing how to loosen social distancing measures across the United States, but that hinges on widespread COVID-19 testing.
Researchers have been trying to untangle COVID-19 infection susceptibility and symptoms by studying a gene that is well known for acting as a receptor for the original SARS coronavirus.
A study published online in Preprints suggests that cannabis extractions containing THC and CBD could help prevent the coronavirus from spreading to and infecting humans. Ultimately, the ...
Under pressure to develop a coronavirus vaccine, researchers have turned to protein synthesis, genetics, and hybrid viruses. It's likely that a mix of these approaches will be used to fight ...
As the world anxiously awaits a remedy for the novel coronavirus, ETH Zurich is also involved in the search for active substances and vaccines. In addition, Professor Jeffrey Bode from the ...
Using CRISPR, Sandia National Lab researchers are genetically engineering antiviral countermeasures to fight the coronavirus—and potentially future outbreaks.
In an interview conducted on May 7, 2020, Pat Thomas and Dr. Stuart Newman discussed the possible origins of COVID-19. Newman, Ph.D., is a professor of cell biology and anatomy at New York ...
23andMe is engaging with millions of people researching the genetics of COVID-19, looking to see if there is a genetic influence in differences in symptoms.
These novel approaches could fail in many ways.
MIT scientists Omar Abudayyeh and Jonathan Gootenberg explain the current state of Covid-19 testing, and how a CRISPR tool may help solve the supply problem.
Ministry of Science and Technology's Department of Biotechnology (DBT) Dr Renu Swarup says that based on the latest WHO consensus, Covid-19 as a 'lab release' theory is likely to be false.